Elicio Therapeutics Inc.
ELTX | NASDAQ
$1.91
+$0.02 (+1.06%)
At close: Sep 21, 2026, 4:00 PM ET
$1.94
+$0.03 (+1.77%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | 28.31M | 2.88M |
Cost of Revenue | 1.13M | 1.18M | 1.17M | 1.06M | 1.23M | 1.82M |
Gross Profit | -1.13M | -1.18M | -1.17M | -1.06M | 27.08M | 1.06M |
Operating Income | -37.71M | -44.99M | -35.75M | -23.73M | -39.31M | -55.27M |
Interest Income | 776K | 777K | 373K | 64.83K | 3.39K | n/a |
Pretax Income | -39.57M | -51.9M | -35.2M | -28.21M | -54.57M | -80.11M |
Net Income | -39.57M | -51.9M | -35.2M | -28.21M | -26.4M | -80.11M |
Selling & General & Admin | 12.81M | 11.33M | 11.9M | 5.63M | 17.78M | 17.46M |
Research & Development | 24.9M | 33.66M | 22.68M | 17.05M | 48.61M | 38.88M |
Other Expenses | -1.13M | -1.18M | n/a | n/a | n/a | n/a |
Operating Expenses | 36.59M | 43.81M | 34.58M | 22.68M | 66.39M | 56.34M |
Interest Expense | 1.13M | 455K | 1.06M | 3.6M | 876.44K | 8.85M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 37.71M | 44.99M | 35.75M | 23.73M | 67.62M | 58.15M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 15.31M | 12.2M | 5.06M | 3.1M | 3.2M | 8.15M |
Shares Outstanding (Diluted) | 15.31M | 12.2M | 5.06M | 3.1M | 3.2M | 8.15M |
EPS (Basic) | -2.58 | -4.25 | -6.96 | -9.10 | -19.32 | -1.93 |
EPS (Diluted) | -2.58 | -4.25 | -6.96 | -9.10 | -19.32 | -1.93 |
EBITDA | -37.31M | -50.27M | -32.97M | -23.55M | -51.93M | -70.63M |
EBIT | -38.44M | -51.44M | -34.14M | -24.61M | -52.73M | -71.26M |
Depreciation & Amortization | 1.13M | 1.18M | 1.17M | 1.06M | 801K | 628K |
Add to Watchlist
Select watchlists to add or remove ELTX